Genetic antiviral program against hepatitis C virus.
Sivov
I G
IG
Bioeffect Research Institute (Federal State Unitary Enterprise), Moscow, Russia.
Samokhvalov
E I
EI
Knyazhev
V A
VA
D000595:Amino Acid Sequence; D000998:Antiviral Agents / Q000494:pharmacology; D001483:Base Sequence; D045744:Cell Line, Tumor; D016679:Genome, Viral; D016174:Hepacivirus / Q000187:drug effects* / Q000235:genetics* / Q000276:immunology; D006801:Humans; D009690:Nucleic Acid Conformation; D009841:Oligonucleotides / Q000494:pharmacology; D010957:Plasmids / Q000235:genetics; D012367:RNA, Viral / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014162:Transfection
D000998:Antiviral Agents; D009841:Oligonucleotides; D012367:RNA, Viral